The world of Pharmaceutical manufacturing is rapidly changing. Gone are the days of “blockbuster” drugs with extended patent protection, to be replaced by an increasingly stringent regulatory environment, fierce generic competition and the emergence of custom drugs – impacting R&D costs, profit margins and manufacturing strategy.
Form as well as function is likely to play a central role in differentiation as businesses look to define competitive advantage in a converging market place.
This will mean a disparate asset base – likely covering liquids, creams, solid dose, injectable and inhalation products, just to name a few.
As new technologies are added, and existing ones maintained the asset base – and with that the associated parts required for maintenance, will continue to grow.
The already challenging task of maintaining an effective parts inventory just got harder.
As with every problem, there is a solution to this one. By leveraging Xtivity’s suite of inventory optimization solutions we will help you ensure your inventory is balanced to support ongoing operations while staying within budgetary constraints.